作者：
Naru,Sato [1]
;
Susumu,Goyama [2]
;
Yu-Hsuan,Chang [1]
;
Masashi,Miyawaki [3]
;
Takeshi,Fujino [4]
;
Shuhei,Koide [5]
;
Tamami,Denda [6]
;
Xiaoxiao,Liu [7]
;
Koji,Ueda [8]
;
Keita,Yamamoto [7]
;
Shuhei,Asada [9]
;
Reina,Takeda [4]
;
Taishi,Yonezawa [4]
;
Yosuke,Tanaka [4]
;
Hiroaki,Honda [9]
;
Yasunori,Ota [6]
;
Takuma,Shibata [10]
;
Motohiro,Sekiya [11]
;
Tomoya,Isobe [12]
;
Chrystelle,Lamagna [13]
;
Esteban,Masuda [13]
;
Atsushi,Iwama [5]
;
Hitoshi,Shimano [11]
;
Jun-Ichiro,Inoue [14]
;
Kensuke,Miyake [10]
;
Toshio,Kitamura [15]
作者单位：
Division of Cellular Therapy, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.;Molecular Pharmacology of Malignant Diseases, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-Ku, Japan.
[1]
Division of Cellular Therapy, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.;Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo, Japan.
[2]
Molecular Pharmacology of Malignant Diseases, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-Ku, Japan.
[3]
Division of Cellular Therapy, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.
[4]
Division of Stem Cell and Molecular Medicine, Centre for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.
[5]
Department of Pathology, The Institute of Medical Science Research Hospital, University of Tokyo, Tokyo, Japan.
[6]
Division of Molecular Oncology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo, Japan.
[7]
Project for Personalized Cancer Medicine, Cancer Precision Medicine Centre, Japanese Foundation for Cancer Research, Tokyo, Japan.
[8]
The Institute of Laboratory Animals, Tokyo Women's Medical University, Tokyo, Japan.
[9]
Department of Microbiology and Immunology, Division of Infectious Genetics, University of Tokyo, Tokyo, Japan.
[10]
Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
[11]
Department of Hematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
[12]
Rigel Pharmaceuticals, Inc., South San Francisco, CA, USA.
[13]
Research Platform Office, The Institute of Medical Science, University of Tokyo, Tokyo, Japan.
[14]
Division of Cellular Therapy, The Institute of Medical Science, University of Tokyo, Tokyo, Japan. kitamura@ims.u-tokyo.ac.jp.;Molecular Pharmacology of Malignant Diseases, Graduate School of Pharmaceutical Sciences, University of Tokyo, Bunkyo-Ku, Japan. kitamura@ims.u-tokyo.ac.jp.;Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan. kitamura@ims.u-tokyo.ac.jp.
[15]
主题词
动物(Animals);动脉粥样硬化(Atherosclerosis);免疫, 先天(Immunity, Innate);阻遏蛋白质类(Repressor Proteins);白细胞介素1受体相关激酶类(Interleukin-1 Receptor-Associated Kinases);突变(Mutation);疾病模型, 动物(Disease Models, Animal);信号传导(Signal Transduction);MAP激酶激酶激酶类(MAP Kinase Kinase Kinases);小鼠, 基因敲除(Mice, Knockout);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);单核细胞(Monocytes);NF-κB(NF-kappa B);巨噬细胞(Macrophages);人类(Humans);男(雄)性(Male);斑块, 动脉粥样硬化(Plaque, Atherosclerotic);主动脉疾病(Aortic Diseases)
DOI
10.1038/s44161-024-00579-w
PMID
39653824
发布时间
2024-12-12
换一批
换一批
